GRIMALDI CLAUDIA has filed 21 insider transactions across 1 company since March 2024.
Most recent transaction: a option exercise of 138462 shares of IGC Pharma, Inc. ($IGC) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | M | Options | 138462 | $0.00 | 221,538.0000 | 88,851,556 | 38.46% | 0.16% |
| April 1, 2026 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | M | Restricted Stock Units | 100000 | $0.00 | 0.0000 | 88,851,556 | 100.00% | 0.11% |
| April 1, 2026 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | M | Common Stock | 138462 | $0.26 | 1,372,714.0000 | 88,851,556 | 11.22% | 0.16% |
| April 1, 2026 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | M | Common Stock | 100000 | $0.00 | 1,234,252.0000 | 88,851,556 | 8.82% | 0.11% |
| Oct. 17, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | G | Common Stock | 50000 | $0.00 | 1,134,252.0000 | 90,457,910 | 4.22% | 0.06% |
| Oct. 17, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | A | Options | 500000 | $0.00 | 500,000.0000 | 90,457,910 | 9999.99% | 0.55% |
| Oct. 17, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | PFO | A | Options | 1000000 | $0.00 | 1,000,000.0000 | 90,457,910 | 9999.99% | 1.11% |
| March 31, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Common Stock | 58333 | $0.00 | 1,084,252.0000 | 77,633,004 | 5.69% | 0.08% |
| March 31, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Common Stock | 100000 | $0.00 | 1,184,252.0000 | 77,633,004 | 9.22% | 0.13% |
| March 31, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Restricted Stock Units | 58333 | $0.00 | 0.0000 | 77,633,004 | 100.00% | 0.08% |
| March 31, 2025 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 77,633,004 | 50.00% | 0.13% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Restricted Stock Units | 95000 | $0.00 | 285,000.0000 | 63,725,084 | 25.00% | 0.15% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | A | Options | 360000 | $0.00 | 360,000.0000 | 63,725,084 | 9999.99% | 0.56% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | A | Options | 550000 | $0.00 | 550,000.0000 | 63,725,084 | 9999.99% | 0.86% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Restricted Stock Units | 100000 | $0.00 | 200,000.0000 | 63,725,084 | 33.33% | 0.16% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Restricted Stock Units | 58334 | $0.00 | 58,332.0000 | 63,725,084 | 50.00% | 0.09% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Restricted Stock Units | 83333 | $0.00 | 0.0000 | 63,725,084 | 100.00% | 0.13% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Common Stock | 95000 | $0.00 | 1,037,154.0000 | 63,725,084 | 10.08% | 0.15% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Common Stock | 100000 | $0.00 | 942,154.0000 | 63,725,084 | 11.87% | 0.16% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Common Stock | 58333 | $0.00 | 842,154.0000 | 63,725,084 | 7.44% | 0.09% |
| March 13, 2024 | IGC Pharma, Inc. | $IGC | GRIMALDI CLAUDIA | Director | M | Common Stock | 83333 | $0.00 | 783,821.0000 | 63,725,084 | 11.90% | 0.13% |